Volcano, a manufacturer of precision guided therapy tools, has entered into a definitive agreement to buy Israel-based Sync-Rx.
Sync-Rx is involved in developing advanced software technologies to facilitate transcatheter cardiovascular interventions using automated online image processing.
The acquisition will enable Volcano to use Sync-Rx’s technology to build various advanced software features on its minimally invasive therapies and help clinicians achieve a more personalized treatment path for their patients as well as documenting outcomes.
Volcano president and chief executive officer Scott Huennekens said Sync-Rx’s technology will allow the company to better integrate and present a wide variety of data in an intuitive manner that creates more meaningful information for the physician and documentation for the hospital.
"This transaction represents a strategic step in the advancement of our multi-modality platform," Huennekens added.
"We see the technology being incorporated seamlessly into our existing multi-modality system with the ability in the future to co-register IVUS images directly on to the angiogram
"Future applications for the Sync-Rx technology in other areas include co-registration of non-invasive imaging with real time intra-body physiology measurements and IVUS peripheral, forward looking IVUS, forward looking intra-cardiac (ICE), and OCT imaging."
The transaction is expected to be closed in December 2012.